Literature DB >> 3277626

Antibody-independent activation of the complement system by mitochondria is mediated by cardiolipin.

M C Peitsch1, J Tschopp, A Kress, H Isliker.   

Abstract

Non-immune activation of the first component of complement (C1) by the heart mitochondrial inner membrane has been investigated. Cardiolipin, the only strong activator of C1 among phospholipids, is present in large amounts in the heart mitochondrial inner membrane. We therefore studied its contribution to C1 activation by mitochondria. The proteins of the mitochondrial inner membrane were found to activate C1 only weakly, in contrast with the phospholipid fraction which induces strong C1 activation. Furthermore, the digestion of mitochondrial inner membranes with proteolytic enzymes did not affect C1 activation. Additional support in favour of cardiolipin being the responsible activator came from competition experiments with mitochondrial creatine kinase (mt-CPK) and adriamycin, known to bind to cardiolipin. Both mt-CPK and adriamycin displaced C1q from the mitochondrial inner membrane. In addition, C1q displaced mt-CPK bound to mitoplasts.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3277626      PMCID: PMC1148730          DOI: 10.1042/bj2490495

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  Activation of C1r by proteolytic cleavage.

Authors:  R J Ziccardi; N R Cooper
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

2.  Binding and activation of the first component of human complement by the lipid A region of lipopolysaccharides.

Authors:  N R Cooper; D C Morrison
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

3.  A new role for C-1-inhibitor in homeostasis: control of activation of the first component of human complement.

Authors:  R J Ziccardi
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

4.  Heart mitochondrial creatine kinase solubilization. Effect of mitochondrial swelling and SH group reagents.

Authors:  B Font; C Vial; D Goldschmidt; D Eichenberger; D C Gautheron
Journal:  Arch Biochem Biophys       Date:  1981-11       Impact factor: 4.013

5.  Purification and radiolabeling of human C1q.

Authors:  A J Tenner; P H Lesavre; N R Cooper
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

6.  Activation of the first component of human complement (C1) by antibody-antigen aggregates.

Authors:  A W Dodds; R B Sim; R R Porter; M A Kerr
Journal:  Biochem J       Date:  1978-11-01       Impact factor: 3.857

7.  Cytochrome c specifically induces non-bilayer structures in cardiolipin-containing model membranes.

Authors:  B de Kruijff; P R Cullis
Journal:  Biochim Biophys Acta       Date:  1980-11-18

8.  Evidence of a specific complex between adriamycin and negatively-charged phospholipids.

Authors:  E Goormaghtigh; P Chatelain; J Caspers; J M Ruysschaert
Journal:  Biochim Biophys Acta       Date:  1980-03-27

9.  The first component of complement. I. Purification and properties of native C1.

Authors:  R G Medicus; R M Chapuis
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

10.  Chromatographic resolution of the first component of human complement into three activities.

Authors:  I H LEPOW; G B NAFF; E W TODD; J PENSKY; C F HINZ
Journal:  J Exp Med       Date:  1963-06-01       Impact factor: 14.307

View more
  13 in total

1.  Membrane attack complex of complement and 20 kDa homologous restriction factor (CD59) in myocardial infarction.

Authors:  T Tada; H Okada; N Okada; H Tateyama; H Suzuki; Y Takahashi; T Eimoto
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

Review 2.  The role of complement in danger sensing and transmission.

Authors:  Jörg Köhl
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  Complement activation by phospholipids: the interplay of factor H and C1q.

Authors:  Lee Aun Tan; Bingbin Yu; Francis C J Sim; Uday Kishore; Robert B Sim
Journal:  Protein Cell       Date:  2010-12-10       Impact factor: 14.870

4.  Apolipoprotein H, a new mediator in the inflammatory changes ensuring in jeopardised human myocardium.

Authors:  H W Niessen; W K Lagrand; H J Rensink; C J Meijer; L Aarden; C E Hack; C Visser
Journal:  J Clin Pathol       Date:  2000-11       Impact factor: 3.411

5.  Decay-accelerating factor in the cardiomyocytes of normal individuals and patients with myocardial infarction.

Authors:  A Zimmermann; H Gerber; V Nussenzweig; H Isliker
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

6.  The role of damage associated molecular pattern molecules in acetaminophen-induced liver injury in mice.

Authors:  Brittany V Martin-Murphy; Michael P Holt; Cynthia Ju
Journal:  Toxicol Lett       Date:  2009-12-01       Impact factor: 4.372

7.  The role of the complement system and the activation fragment C5a in the central nervous system.

Authors:  Trent M Woodruff; Rahasson R Ager; Andrea J Tenner; Peter G Noakes; Stephen M Taylor
Journal:  Neuromolecular Med       Date:  2009-09-11       Impact factor: 3.843

Review 8.  Fueling Inflamm-Aging through Mitochondrial Dysfunction: Mechanisms and Molecular Targets.

Authors:  Anna Picca; Angela Maria Serena Lezza; Christiaan Leeuwenburgh; Vito Pesce; Riccardo Calvani; Francesco Landi; Roberto Bernabei; Emanuele Marzetti
Journal:  Int J Mol Sci       Date:  2017-04-28       Impact factor: 5.923

9.  The human c1q globular domain: structure and recognition of non-immune self ligands.

Authors:  Christine Gaboriaud; Philippe Frachet; Nicole M Thielens; Gérard J Arlaud
Journal:  Front Immunol       Date:  2012-01-06       Impact factor: 7.561

Review 10.  Complexity of complement activation in sepsis.

Authors:  Maciej M Markiewski; Robert A DeAngelis; John D Lambris
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.